The Dundee Drugs Commission could be reconvened to review progress on the implementation of its recommendations.
And city partners are optimistic that funding will soon be received to test ways to integrate substance misuse and mental health services and improve 24-hour crisis care.
Dundee City Council’s policy & resources committee will consider a report on the Dundee Alcohol and Drug Partnership (ADP) – Action Plan for Change at its next meeting on Monday February 22.
The Dundee Partnership – made up of representatives from key local public agencies, academic institutions and representatives of the business, voluntary and community sector – published the action plan in 2019 following the report of the commission.
Hopes to improve 24-hour crisis care in Dundee as funding application is made eveningtelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eveningtelegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications Monday, 01 February 2021 18:00 Hits: 6982
ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.
Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications
ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.